Spots Global Cancer Trial Database for leukine
Every month we try and update this database with for leukine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma | NCT00176280 | Renal Cell Carc... | Leukine Dexamethasone | 18 Years - | University of Kentucky | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma | NCT00308087 | Lymphoma, Folli... | Sargramostim (L... Rituximab | 18 Years - | Sanofi | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia | NCT00446173 | Leukemia | Busulfan Cyclophosphamid... G-CSF GM-CSF | 21 Years - 65 Years | M.D. Anderson Cancer Center | |
| Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma | NCT00600002 | Resectable Panc... Pancreatic Canc... | GM-CSF | 18 Years - | University of California, Irvine | |
| Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma | NCT01939730 | Lymphoma | Rituximab GM-CSF | 18 Years - | M.D. Anderson Cancer Center | |
| Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer | NCT00237575 | Bladder Cancer | gemcitabine cisplatin sargramostim filgrastim | 18 Years - | University of Kentucky | |
| CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma | NCT00455897 | Lymphoma, Non-H... Lymphoma, B-Cel... Lymphoma, Diffu... | GM-CSF CHOP Rituximab | 18 Years - | Massachusetts General Hospital | |
| Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer | NCT00237575 | Bladder Cancer | gemcitabine cisplatin sargramostim filgrastim | 18 Years - | University of Kentucky | |
| Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) | NCT01542684 | Leukemia | Azacytidine GM-CSF | 18 Years - | M.D. Anderson Cancer Center | |
| Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R) | NCT00415857 | Leukemia | Peptide Vaccine... Peginterferon a... Imatinib GM-CSF | 18 Years - | M.D. Anderson Cancer Center | |
| Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma | NCT00176280 | Renal Cell Carc... | Leukine Dexamethasone | 18 Years - | University of Kentucky |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
